About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Adjunctive Study of AL-37807 Ophthalmic Suspension

NCT00620256·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Alcon Research

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Open-angle glaucoma
Ocular hypertension
Must have been on Xalatan for at least 3 months
VA not worse than 0.60

You may not be if

Age related

The record

StatusCompleted

PhasePhase 2

Taking part129

StartedNov 2007

UpdatedDec 5, 2012

Conditions

Open-Angle Glaucoma Ocular Hypertension

Where1

Contact Alcon Call Center at 1-888-451-3937
Fort Worth, Texas, United States

Clareo Health | Adjunctive Study of AL-37807 Ophthalmic Suspension